Rapport Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Rapport Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapport Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapport Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $29M | 952k | 30.34 |
| 2025-09-30 | $27M | 892k | 29.70 |
| 2025-06-30 | $2.8M | 244k | 11.37 |
| 2025-03-31 | $2.0M | 203k | 10.03 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas